tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Harrison, 553 are a BUY (61.58%), 267 are a HOLD (29.73%), 78 are a SELL (8.69%).
Analyst Matthew Harrison, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 67.18% that have a potential upside of 28.69% achieved within 231 days.
Matthew Harrison’s has documented 1,755 price targets and ratings displayed on 92 stocks. The coverage is on Healthcare, Technology, Basic Materials, Energy sectors.
Most recent stock forecast was given on BIIB, Biogen at 09-Oct-2025.
Analyst best performing recommendations are on CMRX (CHIMERIX).
The best stock recommendation documented was for CMRX (CHIMERIX) at 2/23/2016. The price target of $5 was fulfilled within 1 day with a profit of $0.54 (12.11%) receiving and performance score of 121.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$7
$2.91 (71.15%)
15 days ago
(15-Oct-2025)
1/12 (8.33%)
$2.87 (69.49%)
70
Buy
$10
$5.91 (144.50%)
$10
2 months 18 days ago
(12-Aug-2025)
0/4 (0%)
$6.91 (223.62%)
Buy
$5
$0.91 (22.25%)
$8
4 months 11 days ago
(19-Jun-2025)
0/9 (0%)
$2.23 (80.51%)
Sell
$1
$-3.09 (-75.55%)
$2
2 years 14 days ago
(16-Oct-2023)
2/4 (50%)
$0.23 (29.87%)
30
Hold
$5
2 years 2 months 21 days ago
(09-Aug-2023)
1/2 (50%)
$-0.07 (-1.38%)
2
Which stock is Matthew Harrison is most bullish on?
Which stock is Matthew Harrison is most reserved on?
What Year was the first public recommendation made by Matthew Harrison?
